# Butyrate Adjuvant Therapy for Type 1 Diabetes

> **NCT03999853** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Type1diabetes

## Interventions

- **DRUG:** BKR-017

## Key facts

- **NCT ID:** NCT03999853
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-28
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03999853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03999853, "Butyrate Adjuvant Therapy for Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03999853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*